A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6603608.pdf
Reference22 articles.
1. Bagshawe KD (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer 3: 1373–1385
2. Bower M, Newlands ES, Holden L, Short D, Brock C, Rustin GJ, Begent RH, Bagshawe KD (1997) EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 15: 2636–2643; Erratum in: J Clin Oncol 1997 September;15(9):3168.
3. Dobson LS, Lorigan PC, Coleman RE, Hancock BW (2000) Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease. Br J Cancer 82: 1547–1552
4. Farhat F, Culine S, Theodore C, Bekradda M, Terrier-Lacombe MJ, Droz JP (1996) Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience. Cancer 77: 1193–1197
5. Fossa SD, Waehre H, Paus E (1992) The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer. Br J Cancer 66: 181–184
Cited by 88 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of surgery in gestational trophoblastic disease: an overview;International Journal of Gynecologic Cancer;2024-03
2. Chemotherapy is not needed when complete evacuation of gestational choriocarcinoma leads to hCG normalization;European Journal of Surgical Oncology;2024-03
3. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug‐resistant gestational trophoblastic neoplasia: Four case reports and literature review;Cancer Reports;2024-03
4. Non-gestational choriocarcinoma: unraveling the similarities and distinctions from its gestational counterpart;International Journal of Gynecologic Cancer;2023-12-20
5. A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia;Clinical Cancer Research;2023-10-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3